Search clinical trials for: Extracapillary glomerulonephritis
Total 630 results
-
Monia LoriniIstituto Di Ricerche Farmacologiche Mario NegriUnknown
-
Qilu Pharmaceutical Co., Ltd.Recruiting
-
Peking University First HospitalNot yet recruitingObstructive Sleep Apnea | IgA Nephropathy
-
TakedaNot yet recruitingRefractory Lupus NephritisUnited States
-
Adicet Bio, IncNot yet recruitingAutoimmune Diseases | Lupus Nephritis
-
Centre Hospitalier Universitaire de Saint EtienneMinistry of Health, FranceNot yet recruiting
-
Essen BiotechNot yet recruitingAutoimmune Diseases | Systemic Lupus Erythematosus | Systemic Sclerosis | Lupus Nephritis | Microscopic Polyangiitis | Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | Sjogren's Syndrome | Idiopathic Inflammatory Myopathies | Granulomatous PolyangiitisChina
-
Kyverna TherapeuticsRecruitingLupus Nephritis | Lupus Nephritis - WHO Class IV | Lupus Nephritis - WHO Class IIIGermany
-
Centre Hospitalier Universitaire de NiceNot yet recruiting
-
Alexandria UniversityNot yet recruiting
-
Iain BressendorffDitte Hansen MD PhD; Casper Rydahl MD; Anders Nordholm MD PhD; Eva Gravesen MD PhDNot yet recruitingNephrotic Syndrome | Minimal Change Disease | Membranous Nephropathy | Primary Focal Segmental Glomerulosclerosis
-
Mayo ClinicRecruitingFibrillary GlomerulonephritisUnited States
-
Alexion Pharmaceuticals, Inc.RecruitingImmunoglobulin A Nephropathy | IgANSpain, United Kingdom, United States, Italy, Korea, Republic of, Belgium, Germany, Colombia, Japan, China, France, Saudi Arabia, Thailand, Australia, Canada, Brazil, Malaysia, Poland, Taiwan, Austria, Greece, Israel, Netherlands, Arge... and more
-
Assiut UniversityNot yet recruiting
-
Nanjing University School of MedicineRecruitingLupus Nephritis | ANCA-associated Vasculitis | Membranous Nephropathy - PLA2R Induced | IgG4-Related DiseasesChina
-
Lingli DongShenzhen Pregene Biopharma Co., Ltd.RecruitingLupus Nephritis | ANCA Associated VasculitisChina
-
Artiva Biotherapeutics, Inc.RecruitingLupus Nephritis - WHO Class IV | Lupus Nephritis - WHO Class IIIUnited States
-
Assiut UniversityNot yet recruitingNephrolithiasis, Glomerulonephritis, Amyloidosis,AKI, CKD, Tubuli Interstitial | Urinary System Disorders in IBD Patients
-
Beijing Friendship HospitalRecruitingMild Cognitive Impairment | Idiopathic Membranous NephropathyChina
-
Mario Negri Institute for Pharmacological ResearchNot yet recruiting
-
Hager ZanatyNot yet recruitingGut Microbiota Dysbiosis in Lupus Nepheritis
-
Assiut UniversityNot yet recruitingSystemic Lupus Erythematosus | Lupus Nephritis
-
Morehouse School of MedicineJanssen Scientific Affairs, LLCNot yet recruitingLupus Nephritis
-
Nan ShenNovartisNot yet recruitingCharacterize the Molecular Profile of Lupus Nephritis(LN) Patients to Understand Themechanism(s)Contributing to Patient Responsiveness to Soc | Integrated Analysis of LN Patient Molecular Profiling and Clinical Annotations to Understand LNdisease Heterogeneity for Disease Endotype | Validate the Association of the Candidate Biomarker Panel Proposed in Table 3-1 With LN Diseasemonitoring
-
Arrowhead PharmaceuticalsRecruitingIgA NephropathyNew Zealand
-
Omeros CorporationRecruitingC3 Glomerulopathy | Idiopathic Immune Complex-Mediated GlomerulonephritisLithuania, New Zealand, Poland, Tunisia, Turkey, United Kingdom
-
Chinese SLE Treatment And Research GroupRecruiting
-
Christoph AufrichtRecruitingProteinuria | Focal Segmental Glomerulosclerosis | Nephrotic Syndrome | Nephrotic Syndrome Steroid-ResistantAustria
-
Assiut UniversityRecruitingAssessment of Patients With Biopsy Proven Primary Glomerulonephritis Above 18 Years of Age for MFLD DevelopmentEgypt
-
The University of Hong KongNot yet recruitingChronic Kidney Diseases | Lupus NephritisHong Kong
-
ImmPACT BioRecruitingSystemic Lupus Erythematosus | Lupus NephritisUnited States
-
Chengdu Suncadia Medicine Co., Ltd.Not yet recruitingPrimary IgA Nephropathy
-
Sohag UniversityRecruiting
-
Cabaletta BioRecruitingSystemic Lupus Erythematosus | Lupus NephritisUnited States
-
The University of QueenslandUniversity of AdelaideNot yet recruitingPrimary Membranous NephropathyAustralia
-
Ain Shams UniversityNot yet recruiting
-
Yale UniversityUnited States Department of DefenseRecruitingFocal Segmental GlomerulosclerosisUnited States
-
UK Kidney AssociationRecruitingVasculitis | AL Amyloidosis | Tuberous Sclerosis | Fabry Disease | Cystinuria | Focal Segmental Glomerulosclerosis | IgA Nephropathy | Bartter Syndrome | Pure Red Cell Aplasia | Membranous Nephropathy | Atypical Hemolytic Uremic Syndrome | Autosomal Dominant Polycystic Kidney Disease | Cystinosis | Nephronophthisis | BK Nephropathy and other conditionsUnited Kingdom
-
HI-BioRecruitingLupus NephritisUnited States, Argentina, Australia
-
Jiangsu Renocell Biotech CompanyThe Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical...Recruiting
-
Alentis Therapeutics AGRecruitingGlomerulonephritis Rapidly ProgressiveCzechia, Spain, Germany, Denmark, Italy, United Kingdom, France, Switzerland, Sweden, Turkey
-
Mario Negri Institute for Pharmacological ResearchRecruitingDeveloping a Pipeline to Employ RNA-Seq as a Complementary Diagnostic Tool in Rare Diseases (ANTHEM)Healthy | Autosomal Dominant Polycystic Kidney | Atypical Hemolytic Uremic Syndrome | Membranoproliferative GlomerulonephritisItaly
-
Mario Negri Institute for Pharmacological ResearchRecruitingHealthy | Hemolytic-Uremic Syndrome | Membranoproliferative GlomerulonephritisItaly
-
Wang MoRecruitingAnti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | ANCA-Associated GlomerulonephritisChina
-
Sohag UniversityNot yet recruiting
-
Aurinia Pharmaceuticals Inc.Labcorp Corporation of America Holdings, IncNot yet recruitingAdolescent Lupus NephritisUnited States
-
Assistance Publique - Hôpitaux de ParisMinistry of Health, FranceNot yet recruitingANCA Associated Vasculitis | Rapidly Progressive Glomerulonephritis | Crescentic Glomerulonephritis
-
Hansoh BioMedical R&D CompanyRecruitingFocal Segmental Glomerulosclerosis | IgA NephropathyChina
-
Centre Hospitalier Universitaire de NiceNot yet recruitingMembranous NephropathyFrance
-
Kyverna TherapeuticsRecruitingLupus Nephritis | Lupus Nephritis - World Health Organization (WHO) Class III | Lupus Nephritis - WHO Class IVUnited States